• LAST PRICE
    3.3000
  • TODAY'S CHANGE (%)
    Trending Down-0.1800 (-5.1724%)
  • Bid / Lots
    3.2400/ 2
  • Ask / Lots
    3.4400/ 5
  • Open / Previous Close
    3.5000 / 3.4800
  • Day Range
    Low 3.2500
    High 3.5400
  • 52 Week Range
    Low 1.2500
    High 4.6500
  • Volume
    258,676
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • May 9, 2024

  • May 8, 2024

      Show headlines and story abstract
    • 4:09PM ET on Wednesday May 08, 2024 by MT Newswires
      Companies Mentioned: CDXC
      04:09 PM EDT, 05/08/2024 (MT Newswires) -- ...
    • 4:04PM ET on Wednesday May 08, 2024 by Business Wire
      Companies Mentioned: CDXC

      ChromaDex Corp. (NASDAQ:CDXC) today announced financial results for the first quarter of 2024.

      First Quarter 2024 Financial and Recent Operational Highlights

      Total net sales were $22.2 million, with $17.4 million from Tru Niagen(R). Solid gross margin of 60.7%, an increase of 80 basis points, compared to 59.9% from the prior year quarter. Sales and marketing expense as a percentage of net sales was 30.4%, an improvement of 450 basis points, compared to 34.9% from the prior year quarter. Total operating expenses decreased $1.3 million while increasing investments in research and development initiatives. Net loss was $0.5 million or $(0.01) per share, a $1.4 million improvement, or $0.02 per share, from the prior year quarter. Adjusted EBITDA, a non-GAAP measure, improved to a positive $0.7 million from a negative $0.1 million in the prior year quarter. In March 2024, the Tru Niagen(R) product portfolio(1) attained third-party verification through the Alkemist Assured(TM) testing transparency program conducted by Alkemist Labs, a distinguished third-party testing laboratory known for its rigorous analysis of herbal and dietary supplements. This verification reinforces ChromaDex's commitment to excellence by ensuring high-quality, safe ingredients and transparency. In April 2024, ChromaDex expanded distribution of Tru Niagen(R), announcing partnerships with The Vitamin Shoppe and Sprouts Farmers Market, both targeting health-conscious consumers. Tru Niagen(R) is now available in 700 The Vitamin Shoppe and Super Supplements specialty retail locations and online, as well as in 400 Sprouts Farmers Market locations, marking the inaugural launch with a major U.S. grocery chain.

    • 4:04PM ET on Wednesday May 08, 2024 by Dow Jones
      Companies Mentioned: CDXC

      Non-GAAP financial measures are not prepared in accordance with, or an alternative for, generally accepted accounting principles in the United States. The Company's non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.
    • 4:04PM ET on Wednesday May 08, 2024 by Dow Jones
      Companies Mentioned: CDXC

      Non-GAAP financial measures are not prepared in accordance with, or an alternative for, generally accepted accounting principles in the United States. The Company's non-GAAP financial measure is not meant to be considered in isolation or as a substitute for comparable GAAP financial measures and should be read only in conjunction with the company's consolidated financial statements prepared in accordance with GAAP.

Peers Headlines